Histogenics Completes Enrollment for NeoCart Phase III Clinical Trial

Histogenics completed patient enrollment of its NeoCart® Phase III clinical trial, which is being conducted under a Special Protocol Assessment with FDA.

The 245-patient trial is evaluating pain and function improvement of patients treated with NeoCart tissue engineered implant compared to microfracture. Histogenics expects to report top-line...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us